Literature DB >> 31432739

USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.

Kaifeng Niu1,2, Hongbo Fang1, Zixiang Chen1,2, Yuqi Zhu1,2, Qunsong Tan1,2, Di Wei1, Yueyang Li1,2, Adayabalam S Balajee3, Yongliang Zhao1,2.   

Abstract

PRKN/parkin activation through phosphorylation of its ubiquitin and ubiquitin-like domain by PINK1 is critical in mitophagy induction for eliminating the damaged mitochondria. Deubiquitinating enzymes (DUBs) functionally reversing PRKN ubiquitination are critical in controlling the magnitude of PRKN-mediated mitophagy process. However, potential DUBs that directly target PRKN and antagonize its pro-mitophagy effect remains to be identified and characterized. Here, we demonstrated that USP33/VDU1 is localized at the outer membrane of mitochondria and serves as a PRKN DUB through their interaction. Cellular and in vitro assays illustrated that USP33 deubiquitinates PRKN in a DUB activity-dependent manner. USP33 prefers to remove K6, K11, K48 and K63-linked ubiquitin conjugates from PRKN, and deubiquitinates PRKN mainly at Lys435. Mutation of this site leads to a significantly decreased level of K63-, but not K48-linked PRKN ubiquitination. USP33 deficiency enhanced both K48- and K63-linked PRKN ubiquitination, but only K63-linked PRKN ubiquitination was significantly increased under mitochondrial depolarization. Further, USP33 knockdown increased both PRKN protein stabilization and its translocation to depolarized mitochondria leading to the enhancement of mitophagy. Moreover, USP33 silencing protects SH-SY5Y human neuroblastoma cells from the neurotoxin MPTP-induced apoptotic cell death. Our findings convincingly demonstrate that USP33 is a novel PRKN deubiquitinase antagonizing its regulatory roles in mitophagy and SH-SY5Y neuron-like cell survival. Thus, USP33 inhibition may represents an attractive new therapeutic strategy for PD patients.Abbreviations: CCCP: carbonyl cyanide 3-chlorophenylhydrazone; DUB: deubiquitinating enzymes; MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OMM: outer mitochondrial membrane; PD: Parkinson disease; PINK1: PTEN induced kinase 1; PRKN/PARK2: parkin RBR E3 ubiquitin protein ligase; ROS: reactive oxygen species; TM: transmembrane; Ub: ubiquitin; UBA1: ubiquitin like modifier activating enzyme 1; UBE2L3/UbcH7: ubiquitin conjugating enzyme E2 L3; USP33: ubiquitin specific peptidase 33; WT: wild type.

Entities:  

Keywords:  Apoptosis; PRKN/parkin; USP33 deubiquitinase; mitophagy; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31432739      PMCID: PMC7138199          DOI: 10.1080/15548627.2019.1656957

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  30 in total

Review 1.  A genomic and functional inventory of deubiquitinating enzymes.

Authors:  Sebastian M B Nijman; Mark P A Luna-Vargas; Arno Velds; Thijn R Brummelkamp; Annette M G Dirac; Titia K Sixma; René Bernards
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

2.  The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response.

Authors:  Michal Simicek; Sam Lievens; Mathias Laga; Dmytro Guzenko; Vasily N Aushev; Peter Kalev; Maria Francesca Baietti; Sergei V Strelkov; Kris Gevaert; Jan Tavernier; Anna A Sablina
Journal:  Nat Cell Biol       Date:  2013-09-22       Impact factor: 28.824

3.  Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance.

Authors:  Kyoko Ito; Raphaël Turcotte; Jinhua Cui; Samuel E Zimmerman; Sandra Pinho; Toshihide Mizoguchi; Fumio Arai; Judith M Runnels; Clemens Alt; Julie Teruya-Feldstein; Jessica C Mar; Rajat Singh; Toshio Suda; Charles P Lin; Paul S Frenette; Keisuke Ito
Journal:  Science       Date:  2016-10-13       Impact factor: 47.728

Review 4.  The ubiquitin code.

Authors:  David Komander; Michael Rape
Journal:  Annu Rev Biochem       Date:  2012-04-10       Impact factor: 23.643

5.  USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.

Authors:  Ji Li; Vincenzo D'Angiolella; E Scott Seeley; Sehyun Kim; Tetsuo Kobayashi; Wenxiang Fu; Eric I Campos; Michele Pagano; Brian David Dynlacht
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

6.  The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis.

Authors:  Daping Xu; Hongwei Duan; Zaijun Zhang; Wei Cui; Liang Wang; Yewei Sun; Ming Lang; Pui Man Hoi; Yifan Han; Yuqiang Wang; Simon MingYuen Lee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

7.  USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin.

Authors:  Thomas M Durcan; Matthew Y Tang; Joëlle R Pérusse; Eman A Dashti; Miguel A Aguileta; Gian-Luca McLelland; Priti Gros; Thomas A Shaler; Denis Faubert; Benoit Coulombe; Edward A Fon
Journal:  EMBO J       Date:  2014-09-12       Impact factor: 11.598

8.  Characterization of the signal that directs Tom20 to the mitochondrial outer membrane.

Authors:  S Kanaji; J Iwahashi; Y Kida; M Sakaguchi; K Mihara
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

9.  The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.

Authors:  Tom Cornelissen; Dominik Haddad; Fieke Wauters; Cindy Van Humbeeck; Wim Mandemakers; Brianada Koentjoro; Carolyn Sue; Kris Gevaert; Bart De Strooper; Patrik Verstreken; Wim Vandenberghe
Journal:  Hum Mol Genet       Date:  2014-05-22       Impact factor: 6.150

10.  Midline crossing and Slit responsiveness of commissural axons require USP33.

Authors:  Junichi Yuasa-Kawada; Mariko Kinoshita-Kawada; Guan Wu; Yi Rao; Jane Y Wu
Journal:  Nat Neurosci       Date:  2009-08-16       Impact factor: 24.884

View more
  16 in total

1.  USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.

Authors:  Aili Zhang; Zhi Huang; Weiwei Tao; Kui Zhai; Qiulian Wu; Jeremy N Rich; Wenchao Zhou; Shideng Bao
Journal:  EMBO J       Date:  2022-02-22       Impact factor: 11.598

Review 2.  The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.

Authors:  Na Liu; Miao-Miao Lin; Yan Wang
Journal:  Mol Neurobiol       Date:  2022-10-19       Impact factor: 5.682

Review 3.  Mitophagy mechanisms in neuronal physiology and pathology during ageing.

Authors:  Maria Markaki; Dikaia Tsagkari; Nektarios Tavernarakis
Journal:  Biophys Rev       Date:  2021-11-13

4.  Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1/PI3K/AKT pathway in retinoblastoma.

Authors:  Hao Wang; Zhinan Liu; Zhuo Sun; Dong Zhou; Hanyan Mao; Guohua Deng
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

Review 5.  Targeting mitophagy in Parkinson's disease.

Authors:  Emily H Clark; Aurelio Vázquez de la Torre; Tamaki Hoshikawa; Thomas Briston
Journal:  J Biol Chem       Date:  2020-12-24       Impact factor: 5.157

6.  Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.

Authors:  Ga Hyun Park; Joon Hyung Park; Kwang Chul Chung
Journal:  BMB Rep       Date:  2021-12       Impact factor: 4.778

7.  Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches.

Authors:  Eliona Tsefou; Alison S Walker; Emily H Clark; Amy R Hicks; Christin Luft; Kunitoshi Takeda; Toru Watanabe; Bianca Ramazio; James M Staddon; Thomas Briston; Robin Ketteler
Journal:  Biochem J       Date:  2021-12-10       Impact factor: 3.857

Review 8.  Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK/ULK1 Axis.

Authors:  Roberto Iorio; Giuseppe Celenza; Sabrina Petricca
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

Review 9.  Mitochondrial quality surveillance: mitophagy in cardiovascular health and disease.

Authors:  Rachel Y Diao; Åsa B Gustafsson
Journal:  Am J Physiol Cell Physiol       Date:  2021-12-29       Impact factor: 4.249

Review 10.  Mitophagy in the Pathogenesis of Liver Diseases.

Authors:  Po-Yuan Ke
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.